FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, more specifically to a composition of a stabilized single-stranded nucleic acid molecule, which can be used in medicine as an inhibitor of TGF-beta1 gene expression, as well as in preventing or treating pulmonary fibrosis or acute lung injury. Content of the nucleic acid molecule after storage at 25 °C, relative humidity of 60 % for 4 weeks is not less than 80 % relative to content at the moment of storage start.
EFFECT: invention enables to stabilize a nucleic acid molecule consisting of nucleotide sequence SEQ ID NO: 1, at ambient temperature in range of pH from 4,6 to 6,5.
19 cl, 23 dwg, 18 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION STABLY CONTAINING A NUCLEIC ACID MOLECULE | 2015 |
|
RU2723032C2 |
| STABLE COMPOSITIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN AND THEIR USE | 2014 |
|
RU2773172C2 |
| NUCLEIC ACID COMPLEX AND COMPOSITION FOR NUCLEIC ACID DELIVERY | 2008 |
|
RU2465009C2 |
| STABLE BINDING PREPARATIONS BASED ON IgG4 | 2013 |
|
RU2644214C2 |
| PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2604690C2 |
| CARRIER COMPOSITION FOR WELL-TIMED DELIVERY OF NUCLEIC ACIDS | 2008 |
|
RU2476229C2 |
| LIQUID COMPOSITION OF HUMAN GROWTH HORMONE WITH PROLONGED ACTION | 2011 |
|
RU2623026C2 |
| METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A | 2011 |
|
RU2671503C2 |
| METHODS AND COMPOSITIONS FOR DELIVERY OF ARYLSULFATASE A TO CNS | 2011 |
|
RU2783380C2 |
| LIQUID COMPOSITION OF LONG-ACTING ALPHA INTERFERON CONJUGATE | 2011 |
|
RU2613905C2 |
